NCT00392756View on ClinicalTrials.gov

Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)

PHASE1CompletedINTERVENTIONAL
Enrollment

624

Participants

Timeline

Start Date

April 30, 1989

Primary Completion Date

May 16, 2019

Study Completion Date

May 16, 2019

Conditions
Kallmann SyndromeHypogonadotropic HypogonadismGnRH Deficiency
Interventions
DRUG

gonadotropin releasing hormone (GnRH)

pulsatile GnRH is delivered to adult men (18+ yrs) via portable microinfusion pump. A small dose (30 microliters) is delivered subcutaneously every 120 minutes. The initial dose is 25 ng/Kg which is increased until normal serum testosterone levels are achieved.

Trial Locations (1)

02114-2696

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER